https://regulatorynews.com/yuviwel-achondroplasia-physicians Regulatory News en 2026-10-29T11:05:58-04:00 CHMP Backs Second Achondroplasia Drug, Dosed Weekly https://regulatorynews.com/medicovestor-mc001-fast-track-designation Regulatory News en 2026-10-29T09:54:06-04:00 Medicovestor Earns FDA Fast Track for Pancreatic ADC https://regulatorynews.com/xbrane-lucamzi-fda-approval Regulatory News en 2026-10-29T09:54:06-04:00 Xbrane Wins FDA Nod for Lucamzi Eye Biosimilar https://regulatorynews.com/baxter-round-lake-warning-letter Regulatory News en 2026-10-29T05:58:49-04:00 FDA Warns Baxter Over Repeat Sterile-Plant Failures https://regulatorynews.com/pfizer-talzenna-xtandi-mhspc-approval Regulatory News en 2026-10-29T05:58:49-04:00 FDA Expands Talzenna-Xtandi to Earlier Prostate Cancer https://regulatorynews.com/awiqli-pediatric-icodec-physicians Regulatory News en 2026-10-28T10:48:52-04:00 FDA Extends Once-Weekly Awiqli to Pediatric T2D https://regulatorynews.com/zydus-climara-pro-generic-physicians Regulatory News en 2026-10-28T10:48:52-04:00 FDA Approves First Generic Combined Menopause Patch https://regulatorynews.com/cosette-evoxac-oral-solution-nda-approval Regulatory News en 2026-10-28T10:03:12-04:00 Cosette Earns Its First FDA Drug Approval With EVOXAC https://regulatorynews.com/fda-individualized-genome-editing-guidance Regulatory News en 2026-10-28T06:02:49-04:00 FDA Drafts a Path to One BLA Per Gene-Editing Family https://regulatorynews.com/mhra-icotrokinra-icotyde-psoriasis-approval Regulatory News en 2026-10-28T06:02:49-04:00 MHRA Clears First Oral IL-23 Pill for Psoriasis https://regulatorynews.com/sekisui-osom-covid-flu-combo-fda-clearance Regulatory News en 2026-10-28T06:02:49-04:00 FDA Clears Sekisui's OSOM COVID-19/Flu Combo Test